| Literature DB >> 20609862 |
P M Mertes1, K Tajima, M A Regnier-Kimmoun, M Lambert, G Iohom, R M Guéant-Rodriguez, J M Malinovsky.
Abstract
The incidence of immune-mediated anaphylaxis during anesthesia ranges from 1 in 10,000 to 1 in 20,000. Neuromuscular blocking agents are most frequently incriminated, followed by latex and antibiotics, although any drug or substance used may be a culprit. Diagnosis relies on tryptase measurements at the time of the reaction and skin tests, specific immunoglobulin E, or basophil activation assays. Treatment consists of rapid volume expansion and epinephrine administration titrated to symptom severity. Copyright (c) 2010 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20609862 DOI: 10.1016/j.mcna.2010.04.002
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456